ArticleTransboundary and emerging diseases2022
Crimean-Congo Haemorrhagic Fever (CCHF) in animals: Global characterization and evolution from 2006 to 2019.
Article in Transboundary and emerging diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.
- Crimean-Congo hemorrhagic fever in Iran: a systematic review of viral detection in ticks, vector distribution, and data gaps for health system decision-makers.Veterinary research communications · 2026Pooled it
- Theory of change for building stronger wildlife health surveillance systems globally.The Lancet. Planetary health · 2026Review
- Clinical Characteristics, Risk Factors, and Predictors of Fatal Outcomes and Prolonged Hospitalization of Crimean-Congo Hemorrhagic Fever Cases in Basrah, Iraq.Infectious disease reports · 2026Article
- Assessing the risk of diseases with epidemic and pandemic potential in a changing world.Science advances · 2025Article
- Control strategies for emerging infectious diseases: Crimean-Congo hemorrhagic fever management.Health science reports · 2024Article
- Vaccine approaches and treatment aspects against Crimean Congo hemorrhagic fever.Virusdisease · 2024Review
- First Broad-Range Serological Survey of Crimean-Congo Hemorrhagic Fever among Hungarian Livestock.Viruses · 2024Article
- Seroprevalence of Crimean Congo Hemorrhagic Fever Virus in Occupational Settings: Systematic Review and Meta-Analysis.Tropical medicine and infectious disease · 2023Review
- Epidemic intelligence data of Crimean-Congo haemorrhagic fever, European Region, 2012 to 2022: a new opportunity for risk mapping of neglected diseases.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2023Article
- First serological evidence of Crimean-Congo haemorrhagic fever virus in transhumant bovines in Italy.Transboundary and emerging diseases · 2022Article
- Is the COVID-19 pandemic impacting on the risk of African Swine Fever virus (ASFV) introduction into the United States? A short-term assessment of the risk factors.Transboundary and emerging diseases · 2022Article
- Sensitivity of an international notification system for wildlife diseases: A case study using the OIE-WAHIS data on tularemia.Zoonoses and public health · 2022Article
- Crimean-Congo Haemorrhagic Fever (CCHF) in animals: Global characterization and evolution from 2006 to 2019.Transboundary and emerging diseases · 2022Article
- Risk of Crimean Congo haemorrhagic fever virus (CCHFV) introduction and spread in CCHF-free countries in southern and Western Europe: A semi-quantitative risk assessment.One health (Amsterdam, Netherlands) · 2021Article
- Evolution of Rabies in South America and Inter-Species Dynamics (2009-2018).Tropical medicine and infectious disease · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study describes the global distribution and temporal evolution of Crimean-Congo haemorrhagic fever (CCHF) during the period 2006-2019, using the information officially reported to the World Organisation for Animal Health (OIE) by the National Veterinary Services of 210 countries. Eight per cent (CI 95% 4-12) of the countries reported the disease as present at least once during the study period, whereas 82% (CI 95% 77-87) as absent. Information on CCHF status lacked for 10% (CI 95% 6-13) of the countries. The majority of the countries (46%, CI 95% 39-53) never declared CCHF as notifiable, whereas only 27% (CI 95% 21-33) reported the disease as notifiable during the large majority (≥76%) of the study period. The percentage of countries that routinely applied some CCHF control measures were as following: 14% (CI 95% 9-18) passive surveillance, 3% (CI 95% 0.9-5) active surveillance and 1% (CI 95% -0.2-3) control of vector. The time series analysis indicates a significant decreasing trend in the percentage of countries reporting no information, whereas the percentage of countries applying disease control measures significantly increase. This finding may reflect the increased awareness on the importance of the disease and the increased efforts to monitor virus circulation in animals through the application of surveillance programmes. Out of 25 countries reporting cases in humans since 2006, only 12 report cases in animals, pointing out the lack of surveillance capacity in animal populations for some countries. The paucity of CCHF notifications in animals may also reflect the difficulty in identifying the infection due to absent or mild clinical signs. Given that the implementation of surveillance programmes by the Veterinary Services is an essential tool for monitoring the virus circulation and prevent its further spread, National Veterinary Services should keep monitoring and reporting information on CCHF, and at the same time, they should improve the quality and accuracy of the information provided.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.